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ANNOUNCEMENTSThe American Association for
Thoracic Surgery
AATS Cardiovascular Valve Symposium
September 4-6, 2014
Hilton Istanbul, Istanbul, Turkey
The 2014 AATS Cardiovascular Valve Symposium will
bring international leaders in adult, congenital, and adult-
congenital heart valve disease as well as diseases of the
ascending aorta together for three days to discuss the latest
information regarding management guidelines, imaging, pa-
thology, minimally invasive approaches, percutaneous ap-
proaches, surgical techniques, devices, and long-term
results. This innovative program will allow attendees at all
levels to advance their knowledge in aortic and ascending
aorta, mitral, pulmonary, and tricuspid valve disease across
all age spectrums during this AATS Symposium in Istanbul.
DETAILS, INCLUDING A PRELIMINARY PRO-
GRAM, FACULTY, AND HOTEL AND TRAVEL
INFORMATION, CAN BE FOUND ONLINE AT:
www.aats.org/ValveIstanbul
PROGRAM DIRECTORS
David H. Adams
Mount Sinai School of Medicine
New York, New York, USA
Sertac Cicek
Anadolu Medical Center
Istanbul, Turkey
Joseph S. Coselli
Baylor College of Medicine
Houston, Texas, USA
Pedro J. del Nido
Children’s Hospital
Boston, Massachusetts, USA
FACULTY TO INCLUDE:
Atif Akcevin, Istanbul, Turkey
Hakan Akintuerk, Giessen, Germany
Zohair Y. Al Halees, Saudi Arabia
Cem Alhan, Istanbul, Turkey
Emiliano Angeloni, Rome, Italy
Jean E. Bachet, Nogent sur Marne, France
David Barron, Birmingham, United Kingdom
Joseph E. Bavaria, Philadelphia, PA, USA
Emre Belli, Fontenay Aux Roses, France
Suat Buket, Izmir, TurkeyThe Journal of Thoracic and CaDuke E. Cameron, Baltimore, MD, USA
Alain F. Carpentier, Paris, France
Tirone E. David, Toronto, ON, Canada
Roberto Di Bartolomeo, Bologna, Italy
Robert A. Dion, Genk, Belgium
Gilles D. Dreyfus, Monte Carlo, Monaco
Gebrine El-Khoury, Brussels, Belgium
John A. Elefteriades, New Haven, CT, USA
Kahlil Fattouch, Palermo, Italy
Jose Fragata, Lisbon, Portugal
Roland Hetzer, Berlin, Germany
Afksendiyos Kalangos, Geneve, Switzerland
Theodoros Kofidis, Singapore
Rudiger S. Lange, Munich, Germany
Domenico Mazzitelli, Munich, Germany
Christoph A. Nienaber, Rostock, Germany
Aung Ye Oo, Liverpool, United Kingdom
Ourania Preventza, Houston, TX, USA
Hartzell V. Schaff, Rochester, MN, USA
Malakh Shrestha, Hannover, Germany
Victor T. Tsang, London, United Kingdom
Hugo K. I. Vanermen, Aalst, Belgium
Tristan D. Yan, Sydney, AustraliaHeart Valve Summit 2014
September 18-20, 2014
Radisson Blu Aqua Hotel
Chicago, IL, USA
Course Directors:
David H. Adams, MD, FACC
Steven F. Bolling, MD, FACC
Robert O. Bonow, MD, MACC
Howard C. Herrmann, MD, FACC
Nurse Planner:
Michele Langenfeld, RN, MS
Join us in Chicago for the 2014 Heart Valve Summit:
Medical, Surgical and Interventional Decision-Making.
The American Association for Thoracic Surgery and the
American College of Cardiology are once again partnering
to bring together cardiologists and surgeons for
a cooperative, case-based course addressing the rapid
advances in the treatment of valvular heart disease. The
2014 Heart Valve Summit features renowned faculty
who will review cutting-edge, clinically relevant data on
valvular heart disease management and will engage
participants in discussions, debates and potential contro-
versies surrounding real-world cases.
Course Highlights:
 Recently released Valvular Heart Disease Guidelines—
What does this mean for your practice?
 AF/Maze in Mitral Stenosis
 Basics of Aortic Stenosisrdiovascular Surgery c Volume 148, Number 2 757
Announcements Endocarditis
 Failed Mitral Valve Surgery
 Primary Mitral Regurgitation: Anatomy, Imaging,
Decision Making
 Real Mitral Valve Cases
 Rheumatic Valve Disease
 Systolic Anterior Motion
 TAVR
 Tricuspid Valve Disease
 Tough Decision Making
 Valve Regurgitation in Heart Failure
Honored Lecturers:
 William C. Roberts, MD, MACC
Register, Reserve Housing, and View Program at http://
www.cardiosource.org/HeartValve2014AATS Focus on Thoracic Surgery: Novel
Technologies in Lung Cancer
November 21-22, 2014
Renaissance Boston Waterfront Hotel
Boston, MA
Lung cancer is the second most common malignancy in the
Western world and the most common cause of cancer-
related death. Recent innovations in diagnosis, staging,
and management of early stage and locally advanced non–
small cell lung cancer have changed the paradigm for surgi-
cal management of lung cancer patients. A virtual explosion
of technological development has enabled widespread use of
minimally invasive approaches that current and future tho-
racic surgeons must embrace to improve the care of patients
with lung cancer.
Join us in Boston once again as the AATS highlights these
recent developments in its 2014 ‘‘Focus on Thoracic Sur-
gery’’ program, which will focus on Novel Technologies
in Lung Cancer. The faculty includes internationally recog-
nized experts in lung cancer and application of new technol-
ogy for its surgical management. We look forward to seeing
you in Boston!758 The Journal of Thoracic and Cardiovascular SurgPROGRAM COMMITTEE MEMBERS
G. Alec Patterson, Program Director
Washington University School of Medicine
David J. Sugarbaker, Program Director
Brigham and Women’s Hospital
Thomas A. D’Amico
Duke University Medical Center
Shaf Keshavjee
University of Toronto
James D. Luketich
University of Pittsburgh Medical Center
Bryan F. Meyers
Washington University School of Medicine
Scott J. Swanson
Brigham and Women’s Hospital/Harvard Medical School
Dana Farber Cancer Institute
Course Highlights:
 Imaging and Staging
 Surgical Alternatives
 Simulation, Education and Training
 Institutional Impact of New Technology, featuring
Larry Kaiser of Temple University
 Optimal Management of Lung Metastases
 Credentialing/Efficiencies
 Intraoperative Management
 Advanced Minimally Invasive Techniques
For more details and to register, please visit: http://aats.org/
lungcancer.New in 2014—Save the Date
95th Annual Meeting
April 25-29, 2015
Washington State Convention Center
Seattle, WashingtonThe American Association for
Thoracic Surgery Journals
Seminars in Thoracic and Cardiovascular Surgery
Seminars in Thoracic and Cardiovascular Surgery Edi-
tors, Dr Harvey Pass and Dr Todd Rosengart, wouldlike to call your attention to several articles of interest
in the current issue of the journal. ‘‘The 1000th VAD,
the Great Rivalry, and the Grand Experiment of the
Texas Medical Center,’’ a commentary on Dr O.H.
‘‘Bud’’ Frazier’s 1000th VAD implantation has been
co-published in the JTCVS, Texas Heart Institute Journal,
and Seminars.ery c August 2014
